Afib NewsAtrial Fibrillation and Heart Health News
Experts Unveil Tools to Improve Atrial Fibrillation Care Four interventions to enhance the care and treatment of individuals with atrial fibrillation debuted today during a press briefing hosted by The American College of Physicians Foundation’s Initiative on Atrial Fibrillation and Stroke Prevention. Healthy Living: Atrial Fibrillation Atrial fibrillation, it's the most common form of heart irregularity. YNN's Marcie Fraser reports on AFIB causes, symptoms and treatment. New Anti-Clotting Drug May Cut Brain Bleeding Risk: Study THURSDAY, Feb. 2 (HealthDay News) -- A new medication that helps prevent strokes in people with the abnormal heart rhythm disorder known as atrial fibrillation poses less risk of bleeding in the brain than a commonly used drug, research comparing rivaroxaban (Xarelto) and warfarin suggests. Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. cardiologists indicate that they would prescribe Cardiome/Merck’s oral vernakalant and Gilead/Menarini’s ranolazine to 13 percent of their atrial fibrillation patients. Improved care needed for atrial fibrillation About 2.6 million Americans have atrial fibrillation -- or Afib -- but many of them are not getting the kind of healthcare that could prevent a devastating stroke. A national initiative to improve the care of people with Afib was unveiled Tuesday that experts hope will mark a turning point in how the disorder is addressed. Many with atrial fibrillation get improper care LOS ANGELES • About 2.6 million Americans have atrial fibrillation — or Afib — but many of them are not getting the kind of health care that could prevent a devastating stroke. A national initiative to improve the care of people with Afib was unveiled Tuesday that experts hope will mark a turning point in how the disorder is addressed. Omega-3 fatty acids tied to lower heart arrhythmia risk (Reuters) - Older adults who had the highest blood levels of omega-3 fatty acids, most commonly found in fish, were 30 percent less likely to later develop an irregular heartbeat than peers with the lowest blood levels of omega-3s, according to a U.S. study. Up to nine percent of U.S. residents will develop atrial fibrillation by the time they reach their 80s, according to some estimates. The ... Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. cardiologists indicate that they would prescribe Cardiome/Merck’s oral vernakalant and Gilead/Menarini’s ranolazine to 13 percent of their atrial fibrillation patients. In the AVERROES study, apixaban, a novel factor Xa inhibitor, reduced the risk of stroke or systemic embolism in patients with atrial fibrillation who were at high risk of stroke but unsuitable for vitamin K antagonist therapy. Pan-European Stroke Prevention in Atrial Fibrillation Registry - PREFER in AF - Enrols First Patient MUNICH, January 16, 2012 /PRNewswire/ - For European Media Only Collection of real life data from 5,000 atrial fibrillation patients (AF) across seven countries will generate invaluable insights into one of Europe´s leading causes of …
Afib News - If you or someone you care about has Atrial Fibrillation, the Medifocus Guidebook on Atrial Fibrillation will make a major difference in your understanding of the care and treatment of this condition. This one of a kind Guidebook is authored by medical researchers and reviewed by leading specialists nationwide. The Guidebook is the single most up to date afib news resource available (Updated: March 11, 2011) for information on new treatment options and includes carefully selected links to the latest medical research about Atrial Fibrillation that both you and your doctor should be reading. Over 120,000 individuals worldwide have purchased the Medifocus Guidebooks. About the Medifocus Guidebook The Medifocus Guidebook on Atrial Fibrillation explores this health condition in significant depth, and is designed to help you ensure the best outcome by enabling you to: * Take control over your medical condition and act from knowledge rather than fear
* What causes the condition and what are the common signs and symptoms? And so much more... Each Medifocus Guidebook is 100% RISK-FREE - if you are not satisfied with your Guidebook simply return it within 30 days and you will be fully reimbursed. At Medifocus, we believe that fighting illness with facts is the most effective way to empower you to take control over your health. Take advantage of this offer Today and get your Afib under control now!
|
|
Know Your Foe - Get the Information You Need To Beat Afib!
